The Company upholds its commitment to corporate citizenship by actively contributing to the United Nations Sustainable Development Goals (SDGs) through its core biotechnology and pharmaceutical business, with a particular focus on SDG 3: Good Health and Well-being. Guided by its mission to promote global health and well-being, the Company prioritizes social engagement and public welfare initiatives in the area of healthcare.
Through cross-sector collaboration with academic institutions, healthcare providers, industry associations, and non-profit organizations, the Company integrates professional resources and social capital to actively engage in community care initiatives. It places particular emphasis on improving healthcare accessibility and support for underprivileged groups, thereby fulfilling its social responsibility in preventive medicine and health promotion.
By embodying the core value of “giving back to society,” the Company aims to work together with stakeholders to advance health equity and foster sustainable and inclusive social development.
Through cross-sector collaboration with academic institutions, healthcare providers, industry associations, and non-profit organizations, the Company integrates professional resources and social capital to actively engage in community care initiatives. It places particular emphasis on improving healthcare accessibility and support for underprivileged groups, thereby fulfilling its social responsibility in preventive medicine and health promotion.
By embodying the core value of “giving back to society,” the Company aims to work together with stakeholders to advance health equity and foster sustainable and inclusive social development.